ANI Pharmaceuticals, Inc. (ANIP)
79.32
-2.06
(-2.53%)
USD |
NASDAQ |
Dec 30, 16:00
79.60
+0.28
(+0.35%)
After-Hours: 16:49
ANI Pharmaceuticals EPS Diluted (Quarterly): 1.133 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| Intellia Therapeutics, Inc. | -0.9196 |
| Castle Biosciences, Inc. | -0.0172 |
| Amicus Therapeutics, Inc. | 0.0558 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 24.13M |
| Revenue (Quarterly) | 227.81M |
| Total Expenses (Quarterly) | 203.68M |
| Enterprise Value | 2.188B |
| Gross Profit Margin (Quarterly) | 49.07% |
| Profit Margin (Quarterly) | 10.59% |
| Earnings Yield | 2.06% |
| Operating Earnings Yield | 3.33% |
| Normalized Earnings Yield | 1.250 |